A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT05507580 · COMPLETED
Trial details
- NCT number
- NCT05507580
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-29
- Primary completion
- 2024-07-11
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.